Mehta, Sukaran — Insider Profile

Insider Profile

Mehta, Sukaran

🔒 Follow — get an alert on any new filing

$DCBO

Companies Filed At

Open-Market Buys (2yr)

$22K

Buy Value (2yr, open-market)

Dec 31, 2024

Most Recent Trade

Credibility
Score

51%

Hit Rate

-4.1%

Avg 90d Return

+0.9%

Median 90d Return

Evaluated Trades

+18.7%

Best Trade

-47.3%

Worst Trade

Hit rate and returns are based on 37 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

40%

Hit Rate · 90d

-15.4%

Median Alpha · 90d

Closed Buys Evaluated

40%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer high frequency size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 10 closed buys with individual return outcomes available on the Research plan.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 31, 2024	$DCBO Docebo	—	Open Market	Buy	135	$64.41	$9K	43
Dec 31, 2024	$DCBO Docebo	—	Exercise	Sell	245	—	—	43
Dec 31, 2024	$DCBO Docebo	—	Exercise	Buy	245	—	—	43
Dec 20, 2024	$DCBO Docebo	—	Open Market	Buy	201	$67.00	$13K	43
Dec 20, 2024	$DCBO Docebo	—	Exercise	Sell	367	—	—	43
Dec 20, 2024	$DCBO Docebo	—	Exercise	Buy	367	—	—	43
Sep 20, 2024	$DCBO Docebo	—	Buyback	Buy	202	—	—	43
Sep 20, 2024	$DCBO Docebo	—	Exercise	Sell	165	—	—	43
Sep 20, 2024	$DCBO Docebo	—	Exercise	Buy	165	$61.37	$10K	43
Jul 02, 2024	$DCBO Docebo	—	Exercise	Buy	110	$52.45	$6K	43
Jul 02, 2024	$DCBO Docebo	—	Exercise	Sell	110	$52.45	$6K	43
Jul 02, 2024	$DCBO Docebo	—	Buyback	Buy	134	—	—	43
Jun 20, 2024	$DCBO Docebo	—	Exercise	Buy	165	$50.66	$8K	43
Jun 20, 2024	$DCBO Docebo	—	Buyback	Buy	202	—	—	43
Jun 20, 2024	$DCBO Docebo	—	Exercise	Sell	165	$50.66	$8K	43
May 22, 2024	$DCBO Docebo	—	Comp. Grant	Buy	14,985	$50.39	$755K	43
May 22, 2024	$DCBO Docebo	—	Comp. Grant	Buy	7,482	$50.39	$377K	43
Apr 01, 2024	$DCBO Docebo	—	Exercise	Buy	110	$66.38	$7K	43
Apr 01, 2024	$DCBO Docebo	—	Buyback	Buy	135	—	—	43
Apr 01, 2024	$DCBO Docebo	—	Exercise	Sell	110	$66.38	$7K	43
Jan 02, 2024	$DCBO Docebo	—	Open Market	Buy	135	$60.53	$8K	43
Jan 02, 2024	$DCBO Docebo	—	Exercise	Buy	245	—	—	43
Dec 31, 2023	$DCBO Docebo	—	Exercise	Sell	245	—	—	43
Nov 27, 2023	$DCBO Docebo	—	Exercise	Buy	2,800	$54.26	$152K	43
Nov 27, 2023	$DCBO Docebo	—	Exercise	Sell	8,226	$11.06	$91K	43
Nov 27, 2023	$DCBO Docebo	—	Exercise	Sell	2,800	$54.26	$152K	43
Nov 27, 2023	$DCBO Docebo	—	Open Market	Buy	2,756	$64.89	$179K	43
Nov 27, 2023	$DCBO Docebo	—	Open Market	Buy	11,026	$64.90	$716K	43
Nov 27, 2023	$DCBO Docebo	—	Exercise	Buy	8,226	$11.06	$91K	43
Sep 30, 2023	$DCBO Docebo	—	Exercise	Buy	110	$53.99	$6K	43
Sep 30, 2023	$DCBO Docebo	—	Exercise	Sell	110	—	—	43
Sep 30, 2023	$DCBO Docebo	—	Buyback	Buy	134	—	—	43
Jun 30, 2023	$DCBO Docebo	—	Buyback	Buy	135	—	—	43
Jun 30, 2023	$DCBO Docebo	—	Exercise	Buy	110	$49.74	$5K	43
Jun 30, 2023	$DCBO Docebo	—	Exercise	Sell	110	$49.74	$5K	43
Mar 31, 2023	$DCBO Docebo	—	Exercise	Sell	98	$52.72	$5K	43
Mar 31, 2023	$DCBO Docebo	—	Buyback	Buy	147	$52.72	$8K	43
Mar 31, 2023	$DCBO Docebo	—	Exercise	Buy	98	$52.72	$5K	43
Mar 20, 2023	$DCBO Docebo	—	Comp. Grant	Buy	10,879	—	—	43
Mar 20, 2023	$DCBO Docebo	—	Comp. Grant	Buy	5,869	—	—	43
Mar 18, 2023	$DCBO Docebo	—	Exercise	Buy	429	$52.38	$22K	43
Mar 18, 2023	$DCBO Docebo	—	Exercise	Sell	429	—	—	43
Mar 18, 2023	$DCBO Docebo	—	Buyback	Buy	549	—	—	43
May 16, 2022	$DCBO Docebo	—	Open Market	Buy	1,000	$41.10	$41K	43
Mar 18, 2022	$DCBO Docebo	—	Comp. Grant	Buy	3,915	—	—	43
Mar 18, 2022	$DCBO Docebo	—	Comp. Grant	Buy	6,402	—	—	43
Mar 14, 2022	$DCBO Docebo	—	Open Market	Buy	100	$50.22	$5K	43
Mar 14, 2022	$DCBO Docebo	—	Open Market	Buy	100	$50.19	$5K	43
Mar 14, 2022	$DCBO Docebo	—	Open Market	Buy	100	$50.17	$5K	43
Mar 14, 2022	$DCBO Docebo	—	Open Market	Buy	270	$50.14	$14K	43

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.